| Literature DB >> 23613838 |
Sara R Palmer1, James H Miller, Jacqueline Abranches, Lin Zeng, Tristan Lefebure, Vincent P Richards, José A Lemos, Michael J Stanhope, Robert A Burne.
Abstract
High coverage, whole genome shotgun (WGS) sequencing of 57 geographically- and genetically-diverse isolates of Streptococcus mutans from individuals of known dental caries status was recently completed. Of the 57 sequenced strains, fifteen isolates, were selected based primarily on differences in gene content and phenotypic characteristics known to affect virulence and compared with the reference strain UA159. A high degree of variability in these properties was observed between strains, with a broad spectrum of sensitivities to low pH, oxidative stress (air and paraquat) and exposure to competence stimulating peptide (CSP). Significant differences in autolytic behavior and in biofilm development in glucose or sucrose were also observed. Natural genetic competence varied among isolates, and this was correlated to the presence or absence of competence genes, comCDE and comX, and to bacteriocins. In general strains that lacked the ability to become competent possessed fewer genes for bacteriocins and immunity proteins or contained polymorphic variants of these genes. WGS sequence analysis of the pan-genome revealed, for the first time, components of a Type VII secretion system in several S. mutans strains, as well as two putative ORFs that encode possible collagen binding proteins located upstream of the cnm gene, which is associated with host cell invasiveness. The virulence of these particular strains was assessed in a wax-worm model. This is the first study to combine a comprehensive analysis of key virulence-related phenotypes with extensive genomic analysis of a pathogen that evolved closely with humans. Our analysis highlights the phenotypic diversity of S. mutans isolates and indicates that the species has evolved a variety of adaptive strategies to persist in the human oral cavity and, when conditions are favorable, to initiate disease.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23613838 PMCID: PMC3628994 DOI: 10.1371/journal.pone.0061358
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Clinical isolates used in this study.
| Accession # | Lab ID | Strain Name | Host/Sample | Origin/MLST | Serotype |
| AE014133 | Smu159 | UA159 | Dental plaque | NA | c |
| AHRJ00000000 | Smu20 | 15JP3 | ISOC, CF | Brazil/ST12 | c |
| AHRK00000000 | Smu21 | 1SM1 | 29 months, ISOC, CF | Brazil/ST13 | e |
| AHRT00000000 | Smu44 | 11VS1 | 30 months, ISOC, CF | Brazil/ST28 | c |
| AHRV00000000 | Smu52 | NFSM2 | Dental plaque | UK/ST2 | c |
| AHRY00000000 | Smu56 | N29 | Dental plaque | UK/ST11 | c |
| AHRZ00000000 | Smu57 | NMT4863 | Dental plaque | Japan/ST12 | c |
| AHSE00000000 | Smu63 | T4 | CF, SGP | UK/ST23 | c |
| AHSH00000000 | Smu69 | NLM4 | Dental plaque | UK/ST37 | e |
| AHSN00000000 | Smu77 | (N)V1996 | Mutant strain of V403 | US/ST47 | c |
| AHSQ00000000 | Smu81 | SF14 | SGP | US/ST58 | c |
| AHSU00000000 | Smu86 | U2A | Dental plaque | Turkey/ST69 | e |
| AHSZ00000000 | Smu93 | 21 | CA | Iceland/ST73 | e |
| AHTD00000000 | Smu98 | SM1 | SGP | HK/ST116 | c |
| AHRE00000000 | Smu104 | SA41 | SGP | ZA/ST114 | c |
| AHRI00000000 | Smu109 | OMZ175 | ISOC, CF | Switz./NA | f |
V403- human blood isolate from R. Facklam, Centers for Disease Control, Atlanta, Ga [112].
HK- Hong Kong, ZA- South Africa, Switz.- Switzerland. SGP- Supra-gingival plaque, ISOC- initial stages of oral colonization, CF-caries free, CA-caries active.
Growth characteristics of clinical isolates in different stress conditions.
| Growth condition(BHI) | Smu 159 | Smu 20 | Smu 21 | Smu 44 | Smu 52 | Smu 56 | Smu 57 | Smu 63 | Smu 69 | Smu 77 | Smu 81 | Smu 86 | Smu 93 | Smu 98 | Smu 104 | Smu 109 | |
| Td range(min.) | |||||||||||||||||
| pH 7.5 | Td |
| 71±0€ | 73±3 | 69±1€ | 94±3 |
| 78±1 | 80±2 | 114±1 | 106±1 | 84±3 | 70±1€ | 75±2 | 72±1€ | 90±2 | 77±2 |
| 65 to 129 | Lag | 100 | 100 | 160 | 100 | 180 | 160 | 160 | 100 | 120 | 140 | 120 | 100 | 100 | 160 | 100 | 120 |
| ODm | 0.74 | 0.73 | 0.65 | 0.74 | 0.59 | 0.64 | 0.60 | 0.72 | 0.63 | 0.65 | 0.76 | 0.73 | 0.72 | 0.67 | 0.70 | 0.70 | |
| ODf24 | 0.60 | 0.59 | 0.54 | 0.61 | 0.52 | 0.59 | 0.51 | 0.56 | 0.48 | 0.55 | 0.62 | 0.63 | 0.62 | 0.53 | 0.61 | 0.59 | |
| pH 5.5 | Td | 172±5 | 176±3 | 164±5 |
| 211±6 | 264±4 | 237±4 | 226±13 | 233±8 | 259±9 | 255±11 |
| 201±6 | 274±50€ | 214±8 | 222±6 |
| 157 to 328 | Lag | 180 | 200 | 220 | 180 | 200 | 300 | 280 | 260 | 200 | 200 | 220 | 200 | 160 | 200 | 180 | 160 |
| ODm | 0.60 | 0.61 | 0.43 | 0.53 | 0.48 | 0.25 | 0.37 | 0.54 | 0.48 | 0.61 | 0.55 | 0.58 | 0.53 | 0.39 | 0.58 | 0.55 | |
| ODf24 | 0.52 | 0.51 | 0.40 | 0.43 | 0.44 | 0.23 | 0.36 | 0.52 | 0.43 | 0.56 | 0.49 | 0.51 | 0.50 | 0.38 | 0.48 | 0.53 | |
| O2 Air | Td | 87±3 | 107±14 | 94±3 | 88±1 | 134±45 |
| 127±34 | 93±2 | 162±10 | 128±7 | 113±5 | 89±3 |
| 88±5 | 108±15 | 86±6 |
| 86 to 218 | Lag | 220 | 180 | 160 | 120 | 160 | 340 | 200 | 100 | 200 | 280 | 120 | 100 | 100 | 160 | 180 | 160 |
| ODm | 0.54 | 0.50 | 0.57 | 0.61 | 0.48 | 0.51 | 0.46 | 0.57 | 0.46 | 0.50 | 0.63 | 0.65 | 0.67 | 0.64 | 0.57 | 0.67 | |
| ODf15 | 0.41 | 0.26 | 0.25 | 0.53 | 0.22 | 0.49 | 0.36 | 0.46 | 0.31 | 0.32 | 0.41 | 0.49 | 0.36 | 0.39 | 0.29 | 0.35 | |
| ODf45 | 0.29 | 0.34 | 0.20 | 0.52 | 0.30 | 0.46 | 0.34 | 0.22 | 0.22 | 0.21 | 0.61 | 0.57 | 0.44 | 0.33 | 0.62 | 0.54 | |
| Paraquat | Td | 129±9 | 172±6 | 107±3€ | 149±3€ |
| 173±14 | 111±8 | 131±4 | 202±5 | 206±16 |
|
| 117±3 | 122±11 | 142±0 | 137±18 |
| 105 to 387 | Lag | 660 | 660 | 520 | 520 | 700 | 700 | 600 | 400 | 480 | 1000 | NA | 460 | 500 | 800 | 520 | 540 |
| ODm | 0.52 | 0.54 | 0.63 | 0.56 | 0.37 | 0.61 | 0.59 | 0.57 | 0.47 | 0.57 | 0.14 | 0.67 | 0.70 | 0.61 | 0.74 | 0.67 | |
| ODf48 | 0.49 | 0.52 | 0.53 | 0.52 | 0.37 | 0.54 | 0.55 | 0.54 | 0.42 | 0.55 | 0.09 | 0.61 | 0.67 | 0.60 | 0.70 | 0.60 | |
| CSP | Td | 100±0 | 85±3 | 83±3 |
| 98±2 | 137±2 | 78±6 | 95±3 | 104±3 | 133±4 | 87±10 |
| 73±1 | 91±1 | 112±6€ | 89±4€ |
| 68 to 240 | Lag | 200 | 180 | 200 | 180 | 220 | 260 | 240 | 160 | 180 | 200 | 120 | 440 | 140 | 180 | 200 | 200 |
| ODm | 0.60 | 0.63 | 0.58 | 0.71 | 0.58 | 0.58 | 0.52 | 0.52 | 0.56 | 0.53 | 0.71 | 0.29 | 0.66 | 0.64 | 0.65 | 0.64 | |
| ODf20 | 0.46 | 0.46 | 0.43 | 0.59 | 0.46 | 0.50 | 0.44 | 0.39 | 0.45 | 0.46 | 0.58 | 0.28 | 0.58 | 0.54 | 0.56 | 0.52 | |
Mean exponential growth rate (Td) is expressed in minutes and was determined based on growth curves generated in a Bioscreen C Lab System. Lag time is expressed as minutes. ODf indicates the average final OD at the indicated time in hours. ODm indicates the average maximum yield (highest OD reached during growth). Growth curve data is based on duplicate growth curves of two separate cultures (n = 4). Bold values represent the highest and lowest Td under each condition. Statistical differences compared to reference strain UA159 are indicated;
= P≤0.001,
€ = P≤0.01, and
= P≤0.05.
Figure 1Acid killing - Percent survival after exposure to pH 2.8.
Cells were grown to mid-exponential phase, washed in 0.1 M glycine buffer pH 7.4 and re-suspended in 0.1 M glycine pH 2.8. Cells were removed at 15-, 30- and 60-minute intervals, serial diluted and plated. For acid adaptation, cells were harvested at early exponential phase and re-suspended in pH 5.0 media and grown for 2 additional hours. Percent survival was determined based on the number of cells at each time point divided by the number of cells before acid challenge, t0. Data represents the average of two separate experiments performed in duplicate.
Figure 2Autolysis assay.
Late exponential phase cells were suspended in autolysis buffer and OD600 was monitored over 10 hours. Results are the average of triplicate assays and are represented as percent change in OD600 over time.
Mean generation time in BHI with CSP, presence of genetic competence, com genes and bacteriocin distribution among clinical isolates.
| Smu 159 | Smu 20 | Smu 21 | Smu 44 | Smu 52 | Smu 56 | Smu 57 | Smu 63 | Smu 69 | Smu 77 | Smu 81 | Smu 86 | Smu 93 | Smu 98 | Smu 104 | Smu 109 | |
| Td CSP | 100±0 | 85±3 | 83±3 | 68±2* | 98±2* | 137±2 | 78±6* | 95±3 | 104±3† | 133±4 | 87±10* | 240±7 | 73±1* | 91±1 | 112±6 | 89±4 |
| Competence | Y | Y | Y | N | Y | N | N | Y | N | Y | N | Y | Y | N | N | Y |
|
|
|
|
|
|
|
|
| |||||||||
|
| + | − | + | − | + | − | − | − | + | + | + | − | ||||
|
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | ||
|
| +/+ | +/+ | +/− | +/− | +/+ | +/− | −/− | +/+ | −/− | +/+ | −/− | +/+ | +/+ | −/− | +/+ | −/− |
|
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| Smu.1914/ | + | + | + | + | + | + | + | + | + | − | + | + | ||||
| Smu.1909 | + | + | + | + | + | + | + | − | + | + | ||||||
| Smu.1913 | + | ? | + | + | + | + | + | − | + | + | ||||||
| Smu.925/cipI | + | + | + | + | + | + | + | + | + | + | + | − | + | − | + | − |
| Smu.152 | + | + | + | + | + | + | − | + | − | + | − | + | + | − | + | − |
Mean generation times (Td) are same as in Table 1 (CSP). An * indicates Td is not significantly different from Td in BHI without CSP. The † for strains Smu69 indicates Td in CSP was significantly better (P≤0.003) with CSP compared to without CSP. Absence of com genes was determined by whole genome sequence analysis and confirmed by PCR for Smu56 and Smu57. ComC from Smu69 has a truncated comC gene, which is missing the last 3 C-terminal amino acids. For competence Y = yes and N = no. Putative bacteriocins: nlmA/B = Smu.150/Smu.151, nlmD = Smu.423, cipB = Smu.1914, Smu.1906. Putative immunity proteins: Smu.1909, Smu.1913, cipI = Smu.925, Smu.152. (Smu.1906),
= there appears to be a recombination between Smu.1914 and Smu.1906 resulting in a hybrid protein that contains the signal sequence of Smu.1914 and the bacteriocin sequence from Smu.1906. (NlmD),
= mutated signal sequence,
= truncated by 12 aa,
= insertion of two nucleotides resulting in a frameshift at amino acid 50. (Smu.925/CipI),
= ORF starts downstream at 54 bps ATG or GTG site,
= a frame-shift mutation results in a premature stop codon leading to a truncation of 4 aa at C-terminus,
= truncated by 7 aa at C-terminus due to a frame-shift mutation.
Figure 3Sensitivity to CSP.
Growth sensitivity to CSP correlates with level of competence. A) Growth curves of UA159 and Smu86 in various concentrations of CSP. B) Transformation assay with various concentrations of CSP. The photograph of the plates is representative of duplicate biological replicates.
Figure 4Biofilm formation by clinical isolates in semi-defined media with 20 mM glucose or sucrose.
Top panel shows numeric values of crystal violet biofilm assay (OD575 of eluted solution). Statistically significant differences compared to UA159 are indicated, ** = P≤0.001, * = P≤0.05. Bottom panel shows a picture of the crystal violet stained biofilm for each strain in the micro-titer plate wells before de-stain procedure.
Figure 5Expression of cell-wall associated proteins involved in biofilm formation and sucrose mediated cell clumping.
A) Cell associated protein extracts were from cell pellets harvested from mid-log BHI cultures. Proteins were separated on a 4–8% XT Criterion (BioRad) tris-acetate gel, transferred to a nitrocellulose membrane and stained with BioRad Colloidal Gold Total Protein Stain. For Western blot, proteins were transferred to PVDF membranes and reacted with polyclonal antisera that recognizes both GtfB and GtfC. B) Photos were taken after 48 hours of growth in BHI supplemented with 0.3% sucrose.
Absence of two-component systems in clinical isolates.
| TCS HK/RR | Smu 159 | Smu 20 | Smu 21 | Smu 44 | Smu 52 | Smu 56 | Smu 57 | Smu 63 | Smu 69 | Smu 77 | Smu 81 | Smu 86 | Smu 93 | Smu 98 | Smu 104 | Smu 109 |
| TCS-1 (Smu.1516/.1517) | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ |
| TCS-2 (Smu.1128/.1129) | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ |
| TCS-3 (Smu.1145c/.1146c) | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ |
| TCS-4 (Smu.928/.927) | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ |
| TCS-5 (Smu.1814/.1815) | +/+ | −/− | −/− | +/+ | +/+ | −/− | −/− | −/− | +/+ | −/− | −/− | +/+ | −/− | −/− | −/− | −/− |
| TCS-6 (Smu.660/.659) | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ |
| TCS-7 (Smu.1037c/.1038c) | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | −/− | +/+ | +/+ | +/+ | +/+ | +/− |
| TCS-8 (Smu.1009/.1008) | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ |
| TCS-9 (Smu.1965c/.1964c) | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ |
| TCS-10 (Smu.577/.576) | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ |
| TCS-11 (Smu.486/.487) | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ |
| TCS-12 (Smu.1548c/.1547c) | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ |
| TCS-13 (Smu.1916/.1917) | +/+ | +/+ | +/+ | +/+ | +/+ | −/− | −/− | +/+ | +/+ | +/+ | +/− | +/+ | +/+ | +/+ | +/+ | +/+ |
| TCS-14 (Smu.45/.46) | +/+ | −/− | −/− | −/− | +/+ | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− |
| TCS-15 (CmpR/ComP) | −/− | −/− | +/+ | −/− | −/− | −/− | −/− | −/− | −/− | +/+ | +/+ | +/+ | −/− | +/+ | −/− | +/+ |
| Orphan RR (Smu.1924) | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
Presence or absence of genes are indicated as a + or − sign. TCS-1 = VicKR, TCS-2 = CiaHR, TCS-3 = CovSR, TCS-4 = KinF/LlrF, TCS-5 = ScnKR, TCS-6 = SpaKR, TCS-7 = PhoR/YcbL, TCS-8 = KinG/LlrG, TCS-9 = LevSR, TCS-10 = LysST, TCS-11 = LiaSR, TCS-12 = HK11/RR11, TCS-13 = ComDE, Orphan RR = GcrR.
= presence of genes Smu.1008-Smu.1009 was confirmed by PCR, but gene sequence is unknown for these proteins in Smu81, so point mutations could not be ruled out.
HK- sensor histidine kinase, RR- response regulator.
Figure 6Kaplan-Meier killing curves of G. mellonella larvae (wax worms) inoculated with S. mutans strains.
Graphs show percent survival of G. mellonella after injection of 5 µl inoculums. CFU/100 µl of each inoculum is provided in legend. A) Smu81, Smu86, Smu77 compared to UA159 (non-virulent) and OMZ175. B) Smu44, Smu26, Smu80 and Smu102 compared to UA159. * Indicates significant difference (P≥0.05) compared to OMZ175.